The results reveal that GALNT1 expression level is often increased in HCC tumors, p < 0.05, with 60% of the HCC patients exhibiting increased GALNT1 expression levels in the tumors compared with the adjacent non-tumor tissues. This evidence concerns the gene GALNT1 and hepatocellular carcinoma.